CA1023266A - Enterically coated biologicals and tge vaccine - Google Patents

Enterically coated biologicals and tge vaccine

Info

Publication number: CA1023266A
Authority: CA; Canada
Prior art keywords: tge; biologicals; vaccine; enterically coated; enterically
Prior art date: 1972-08-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA179,663A

Other languages

French (fr)

Other versions

CA179663S (en

Inventor

Deam H. Ferris

Angel S. Arambulo

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Illinois Foundation

Original Assignee

University of Illinois Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-08-30

Filing date

1973-08-27

Publication date

1977-12-27

1972-08-30 Priority claimed from US00285036A external-priority patent/US3823228A/en

1973-08-27 Application filed by University of Illinois Foundation filed Critical University of Illinois Foundation

1977-12-27 Application granted granted Critical

1977-12-27 Publication of CA1023266A publication Critical patent/CA1023266A/en

Status Expired legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A61K39/225—Porcine transmissible gastroenteritis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

CA179,663A 1972-08-30 1973-08-27 Enterically coated biologicals and tge vaccine Expired CA1023266A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US00285036A US3823228A (en)	1971-09-29	1972-08-30	Tge virus vaccine

Publications (1)

Publication Number	Publication Date
CA1023266A true CA1023266A (en)	1977-12-27

Family

ID=23092469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA179,663A Expired CA1023266A (en)	1972-08-30	1973-08-27	Enterically coated biologicals and tge vaccine

Country Status (9)

Country	Link
JP (1)	JPS535371B2 (en)
AR (1)	AR197158A1 (en)
AU (1)	AU5949773A (en)
CA (1)	CA1023266A (en)
DE (1)	DE2343570A1 (en)
FR (1)	FR2197576B1 (en)
GB (1)	GB1440214A (en)
NL (1)	NL7312032A (en)
PH (1)	PH10296A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811128A (en) *	1986-10-24	1998-09-22	Southern Research Institute	Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0009577A1 (en) *	1978-08-18	1980-04-16	Burns-Biotec Laboratories Inc.	An oral vaccine preparation and a method for increasing the resistance of swine to swine-dysentery infection
JPS584561Y2 (en) *	1980-11-26	1983-01-26	日本濾過器株式会社	bubble separator
DK150008C (en) *	1981-11-20	1987-05-25	Benzon As Alfred	PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL ORAL POLYDEPOT PREPARATION
DE19741114C2 (en) *	1997-09-12	2002-10-24	Riemser Arzneimittel Ag	Moisture-stable and enteric drug form for fish

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3458621A (en) *	1966-08-31	1969-07-29	American Home Prod	Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3519710A (en) *	1967-08-10	1970-07-07	Edmund P Bass	Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth

1973
- 1973-08-22 AU AU59497/73A patent/AU5949773A/en not_active Expired
- 1973-08-27 CA CA179,663A patent/CA1023266A/en not_active Expired
- 1973-08-29 AR AR249824A patent/AR197158A1/en active
- 1973-08-29 DE DE19732343570 patent/DE2343570A1/en active Pending
- 1973-08-30 JP JP9679673A patent/JPS535371B2/ja not_active Expired
- 1973-08-30 FR FR7331447A patent/FR2197576B1/fr not_active Expired
- 1973-08-30 PH PH14977A patent/PH10296A/en unknown
- 1973-08-31 NL NL7312032A patent/NL7312032A/en unknown
- 1973-09-05 GB GB4181273A patent/GB1440214A/en not_active Expired

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811128A (en) *	1986-10-24	1998-09-22	Southern Research Institute	Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US5814344A (en) *	1986-10-24	1998-09-29	Southern Research Institute	Method for delivering bioactive agents into and through the mucosally associated lymphoid tissues and controlling their release
US5820883A (en) *	1986-10-24	1998-10-13	Southern Research Institute	Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release
US5853763A (en) *	1986-10-24	1998-12-29	Southern Research Institute	Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release
US5942252A (en) *	1986-10-24	1999-08-24	Southern Research Institute	Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release
US6024983A (en) *	1986-10-24	2000-02-15	Southern Research Institute	Composition for delivering bioactive agents for immune response and its preparation

Also Published As

Publication number	Publication date
AR197158A1 (en)	1974-03-15
PH10296A (en)	1976-11-10
AU5949773A (en)	1975-02-27
FR2197576B1 (en)	1976-09-03
NL7312032A (en)	1975-03-04
DE2343570A1 (en)	1974-03-14
FR2197576A1 (en)	1974-03-29
JPS535371B2 (en)	1978-02-27
JPS4962618A (en)	1974-06-18
GB1440214A (en)	1976-06-23

Publication	Publication Date	Title
CA1024555A (en)	1978-01-17	Scaffold and like structures
CA972006A (en)	1975-07-29	Intermittent sprinkler and system
CA1009138A (en)	1977-04-26	Cooking system
CA1027955A (en)	1978-03-14	Amino-phenyl-ethanolamines and oxazolidines thereof
AU469003B2 (en)	1976-01-29	Alignment and control system
CA1023266A (en)	1977-12-27	Enterically coated biologicals and tge vaccine
CA1011740A (en)	1977-06-07	Phthalides and preparation thereof
AU467736B2 (en)	1975-12-11	Pteridinones and the preparation thereof
CA1005451A (en)	1977-02-15	Unsaturated diorganoetains mercaptides - its preparation and its use
CA902628A (en)	1972-06-13	Silylorganocarbamates and preparation
CA905848A (en)	1972-07-25	Vaccines
CA916592A (en)	1972-12-12	Viral vaccines
CA909735A (en)	1972-09-12	Mortar gun and disc therefor
CA936209A (en)	1973-10-30	Combination humidistat and heater
CA891528A (en)	1972-01-25	N-acylbenzohydroxamate and preparation thereof
CA895335A (en)	1972-03-14	Perfluoroperoxyhypochlorites and preparation thereof
AU483281B2 (en)	1975-06-12	Phthalidides and preparation thereof
CA908174A (en)	1972-08-22	Thienodiazepines and preparations thereof
CA900711A (en)	1972-05-23	Drying and/or heating devices
CA906128A (en)	1972-07-25	Aminooxyorganopolysiloxanes and preparation
CA1007720A (en)	1977-03-29	Digitally controlled attenuator
CA905959A (en)	1972-07-25	Imidoylureas and imidoylthioureas
AU474112B2 (en)	1976-07-15	Indenopyran and indenothiopyranalkylamines
AU481557B2 (en)	1975-04-17	Scaffold and like structures
CA900493A (en)	1972-05-16	Valeroamide intermediates and preparation thereof